These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23700058)

  • 1. The principle and practice of reinduction therapy (in ALL): repetita iuvant!
    Masera G; Conter V; Gaynon PS
    Klin Padiatr; 2013 May; 225 Suppl 1():S57-61. PubMed ID: 23700058
    [No Abstract]   [Full Text] [Related]  

  • 2. Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000.
    Schrappe M; Möricke A; Reiter A; Henze G; Welte K; Gadner H; Ludwig WD; Ritter J; Harbott J; Mann G; Klingebiel T; Gruhn B; Niemeyer C; Kremens B; Niggli F; Debatin KM; Ratei R; Stanulla M; Beier R; Cario G; Schrauder A; Zimmermann M
    Klin Padiatr; 2013 May; 225 Suppl 1():S62-72. PubMed ID: 23700060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once upon a time--a personal view on episodes in leukemia research in Germany, and beyond.
    Gaynon P
    Klin Padiatr; 2013 May; 225 Suppl 1():S5. PubMed ID: 23700056
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prof. Dr. Hansjörg Riehm, a life devoted to science].
    Klingebiel T; Schrappe M
    Klin Padiatr; 2013 May; 225 Suppl 1():S9-14. PubMed ID: 23700067
    [No Abstract]   [Full Text] [Related]  

  • 5. [Greetings from the SIOP].
    Calaminus G
    Klin Padiatr; 2013 May; 225 Suppl 1():S8. PubMed ID: 23700064
    [No Abstract]   [Full Text] [Related]  

  • 6. [Greetings from the Society of Pediatric Oncology and Hematology (GPOH)].
    Eggert A
    Klin Padiatr; 2013 May; 225 Suppl 1():S7. PubMed ID: 23700061
    [No Abstract]   [Full Text] [Related]  

  • 7. 50 Years Ago in The Journal of Pediatrics: A Study of "Total Therapy" of Acute Lymphocytic Leukemia in Children.
    Ferguson WS
    J Pediatr; 2018 Mar; 194():115. PubMed ID: 29478493
    [No Abstract]   [Full Text] [Related]  

  • 8. Old man river. The flow of pediatric oncology.
    D'Angio GJ; Vietti TJ
    Hematol Oncol Clin North Am; 2001 Aug; 15(4):599-607, vii. PubMed ID: 11676275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A historical perspective on the development of the cytarabine (7days) and daunorubicin (3days) treatment regimen for acute myelogenous leukemia: 2013 the 40th anniversary of 7+3.
    Lichtman MA
    Blood Cells Mol Dis; 2013 Feb; 50(2):119-30. PubMed ID: 23154039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Greetings from DGKJ].
    Wagner N
    Klin Padiatr; 2013 May; 225 Suppl 1():S6. PubMed ID: 23700059
    [No Abstract]   [Full Text] [Related]  

  • 11. 50 Years Ago in The Journal of Pediatrics: Sequential Therapy of Acute Leukemia in Childhood.
    Heikamp E; Rau R
    J Pediatr; 2017 Apr; 183():140. PubMed ID: 28343531
    [No Abstract]   [Full Text] [Related]  

  • 12. The life and work of Professor Riehm from a participant's perspective.
    Gadner H
    Klin Padiatr; 2013 May; 225 Suppl 1():S3-4. PubMed ID: 23700052
    [No Abstract]   [Full Text] [Related]  

  • 13. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphoblastic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Büyükçelik A; Yalçin B; Utkan G; Doruk H
    Cancer; 2004 Sep; 101(5):1100-1; author reply 1101. PubMed ID: 15329922
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progress in the field of hematology in the last 100 years: Medical history of acute leukemia].
    Ono R
    Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2084-9. PubMed ID: 12187682
    [No Abstract]   [Full Text] [Related]  

  • 15. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forty-five-year follow-up of a childhood leukemia survivor: serendipity or karma?
    Ravindranath Y
    Med Pediatr Oncol; 1999 Oct; 33(4):409-10. PubMed ID: 10491554
    [No Abstract]   [Full Text] [Related]  

  • 17. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
    Paśnicki M
    Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intravenous immunoglobulin preparations in the adjuvant treatment of acute lymphoblastic leukemia in children].
    Rokicka-Milewska R; Derulska D; Skwarska E
    Pol Tyg Lek; 1988 Aug; 43(34):1085-7. PubMed ID: 3150782
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
    Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.